INTC · 10-Q · 2026Q3 · Full report

Operating Expense Trends

INTEL CORP · 2026-10-30 · Importance 49 · Surprise 32 · No source text

Combined R&D and MG&A expenses were $4.5 billion in Q3 2026, up 4% year over year, and $13.5 billion YTD, down 4%. R&D expense increased $259 million, or 8%, in Q3 because of process-technology and product investments and higher incentive compensation; YTD R&D decreased $322 million, or 3%, due to cost reductions and Altera's deconsolidation. MG&A fell $99 million, or 9%, in Q3 and $207 million, or 6%, YTD, reflecting cost-reduction measures and Altera's deconsolidation, partly offset by higher share-based compensation. R&D and MG&A were 27.4% of revenue in Q3 and 29.2% YTD, compared with 31.9% and 35.7% in the prior-year periods.

Key facts

• Intel's total R&D and MG&A expenses were $4.5 billion in Q3 2026, up 4% year over year, and $13.5 billion in YTD 2026, down 4%. source
• Intel R&D expenses were $259 million, or 8%, higher in Q3 2026 than Q3 2025, driven by process-technology and product investments and higher incentive-based cash compensation. source
• Intel R&D expenses were $322 million, or 3%, lower in YTD 2026 than YTD 2025, driven by cost reductions and Altera deconsolidation, partly offset by higher incentive-based cash compensation. source
• Intel MG&A expenses were $207 million, or 6%, lower in YTD 2026 than YTD 2025, driven by cost reductions and Altera deconsolidation, partly offset by higher share-based compensation. source
• Intel MG&A expenses were $99 million, or 9%, lower in Q3 2026 than Q3 2025, driven by cost reductions and Altera deconsolidation, partly offset by higher share-based compensation. source
• Intel expects total R&D and MG&A expenses to decrease in 2026 relative to recent historical periods because of its 2025 and 2024 restructuring plans, cost reductions and Altera deconsolidation. source

Impact estimates